RE
Revelation Biosciences, Inc.
REVBW · NASDAQ
$0.01 +1.85% (+$0.00)
1M -41.49%
Market Cap $32.6K
P/E Ratio -
Div. Yield -
ROE 100.20%
Bulios Fair Price
$0.01
81.8% upside
Current Price
$0.0055
Undervalued Fair Value Overvalued
According to Bulios Fair Price, REVBW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.00x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 103.44%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 100.20%
ROA 86.02%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 6.21x
Debt/Equity 0.07x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 594.17%
Profitable years 0
Beta -0.12x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about REVBW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Rolke
Employees
8
Headquarters
San Diego
Upcoming events
05 NOV
Earnings
Upcoming earnings report